131 related articles for article (PubMed ID: 16356493)
21. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis.
Chadwick RB; Jiang GL; Bennington GA; Yuan B; Johnson CK; Stevens MW; Niemann TH; Peltomaki P; Huang S; de la Chapelle A
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2662-7. PubMed ID: 10688904
[TBL] [Abstract][Full Text] [Related]
22. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36.
Poetsch M; Dittberner T; Woenckhaus C
Oncogene; 2002 May; 21(19):3038-42. PubMed ID: 12082534
[TBL] [Abstract][Full Text] [Related]
23. Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.
Geli J; Nord B; Frisk T; Edström Elder E; Ekström TJ; Carling T; Bäckdahl M; Larsson C
Int J Oncol; 2005 May; 26(5):1385-91. PubMed ID: 15809732
[TBL] [Abstract][Full Text] [Related]
24. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional repression mediated by the PR domain zinc finger gene RIZ.
Xie M; Shao G; Buyse IM; Huang S
J Biol Chem; 1997 Oct; 272(42):26360-6. PubMed ID: 9334209
[TBL] [Abstract][Full Text] [Related]
26. Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells.
Davidson NE; Prestigiacomo LJ; Hahm HA
Cancer Res; 1993 Jan; 53(2):291-7. PubMed ID: 8417822
[TBL] [Abstract][Full Text] [Related]
27. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
28. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
29. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells.
Catalano MG; Costantino L; Frairia R; Boccuzzi G; Fortunati N
Horm Metab Res; 2007 Apr; 39(4):288-94. PubMed ID: 17447168
[TBL] [Abstract][Full Text] [Related]
30. PRDM5 is silenced in human cancers and has growth suppressive activities.
Deng Q; Huang S
Oncogene; 2004 Jun; 23(28):4903-10. PubMed ID: 15077163
[TBL] [Abstract][Full Text] [Related]
31. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
32. c-myc promoter binding protein regulates the cellular response to an altered glucose concentration.
Sedoris KC; Thomas SD; Miller DM
Biochemistry; 2007 Jul; 46(29):8659-68. PubMed ID: 17595061
[TBL] [Abstract][Full Text] [Related]
33. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells.
Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC
Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568
[TBL] [Abstract][Full Text] [Related]
34. Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells.
Fontana JA; Nervi C; Shao ZM; Jetten AM
Cancer Res; 1992 Jul; 52(14):3938-45. PubMed ID: 1319834
[TBL] [Abstract][Full Text] [Related]
35. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms in the Rb-binding zinc finger gene RIZ and the risk of lung cancer.
Yoon KA; Park S; Hwangbo B; Shin HD; Cheong HS; Shin HR; Lee JS
Carcinogenesis; 2007 Sep; 28(9):1971-7. PubMed ID: 17693662
[TBL] [Abstract][Full Text] [Related]
37. The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancers.
Huang S
Front Biosci; 1999 Jun; 4():D528-32. PubMed ID: 10369808
[TBL] [Abstract][Full Text] [Related]
38. Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36.
Buyse IM; Takahashi EI; Huang S
Genomics; 1996 May; 34(1):119-21. PubMed ID: 8661032
[TBL] [Abstract][Full Text] [Related]
39. RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum.
Sakurada K; Furukawa T; Kato Y; Kayama T; Huang S; Horii A
Genes Chromosomes Cancer; 2001 Feb; 30(2):207-11. PubMed ID: 11135439
[TBL] [Abstract][Full Text] [Related]
40. Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation.
Di Zazzo E; Rienzo M; Casamassimi A; De Rosa C; Medici N; Gazzerro P; Bifulco M; Abbondanza C
J Transl Med; 2023 Mar; 21(1):217. PubMed ID: 36964555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
